Profil
Geert-Jan Mulder founded Forbion Capital Partners Management Holding BV in 2007, where he is working as Managing Partner from 2018.
Dr. Mulder also currently works at Promedior, Inc., as Director, Sanifit Therapeutics SA, as Director, Exosome Diagnostics, Inc., as Director, Amakem NV, as Director from 2015, NeRRe Therapeutics Ltd., as Director, KaNDy Therapeutics Ltd., as Director, NeRRe Therapeutics Holdings Ltd., as Director from 2017, Complement Therapeutics Ltd., as Director, AM-Pharma Holding BV, as Member-Supervisory Board, and AM-Pharma BV, as Member-Supervisory Board.
Dr. Mulder also formerly worked at bluebird bio, Inc., as Director from 2010 to 2013, PanGenetics BV, as Director-Supervisory Board, AAC Capital Partners Ltd., as Director, Transave, Inc., as Director, and ario pharma Ltd., as Director.
Dr. Mulder received his graduate degree and doctorate degree from the University of Utrecht.
Postes actifs de Geert-Jan Mulder
| Sociétés | Poste | Début |
|---|---|---|
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Fondateur | 08/01/2007 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Directeur/Membre du Conseil | - |
Promedior, Inc.
Promedior, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics to treat fibrotic diseases | Directeur/Membre du Conseil | 23/02/2011 |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Directeur/Membre du Conseil | - |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Directeur/Membre du Conseil | - |
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services Provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity | Directeur/Membre du Conseil | - |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Directeur/Membre du Conseil | 28/09/2015 |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology Develops medicines for female sex hormone disorders | Directeur/Membre du Conseil | - |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities | Directeur/Membre du Conseil | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Geert-Jan Mulder
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Geert-Jan Mulder
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
PanGenetics BV
PanGenetics BV Miscellaneous Commercial ServicesCommercial Services Researches and develops antibody-based therapeutic products | Commercial Services |
AAC Capital Partners Ltd.
AAC Capital Partners Ltd. Financial ConglomeratesFinance Alternative investment manager | Finance |
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Health Technology |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities | Health Technology |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Promedior, Inc.
Promedior, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics to treat fibrotic diseases | Health Technology |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Health Services |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Health Services |
ario pharma Ltd.
ario pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of respiratory indications | Health Technology |
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services Provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity | Distribution Services |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology Develops medicines for female sex hormone disorders | Health Technology |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Commercial Services |
Complement Therapeutics Ltd.
Complement Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops complement medicines | Health Technology |
















